Differences in disease activity measures in patients with rheumatoid arthritis who achieved DAS, SDAI, or CDAI remission but not Boolean remission

Aletaha Daniel; Wang Xin; Zhong Sheng; Florentinus Stefan; Monastiriakos Kelly; Smolen Josef S.

首页> 外文期刊>Seminars in Arthritis and Rheumatism >Differences in disease activity measures in patients with rheumatoid arthritis who achieved DAS, SDAI, or CDAI remission but not Boolean remission

【24h】

Differences in disease activity measures in patients with rheumatoid arthritis who achieved DAS, SDAI, or CDAI remission but not Boolean remission

机译：患有DAS，SDAI或CDAI缓解但没有布尔缓解的类风湿性关节炎患者疾病活动措施的差异

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Seminars in Arthritis and Rheumatism》 |2020年第4期|共2页
作者
Aletaha Daniel; Wang Xin; Zhong Sheng; Florentinus Stefan; Monastiriakos Kelly; Smolen Josef S.;
展开▼
作者单位

Med Univ Vienna Waehringer Guertel 18-20 A-1090 Vienna Austria;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类免疫性疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Clinical deep remission and related factors in a large cohort of patients with rheumatoid arthritis [J] . Jia-Jia Liu, Lian-Jie Shi, Ji Li, 中华医学杂志（英文版） . 2019,第009期
2. High Remission Rates in a Brazilian Cohort of Initial Rheumatoid Arthritis after 15 Years of Follow-Up [J] . Heloisa Lima Heller, Ana Paula Gomides Reis, Cleandro Albuquerque, 风湿病与自身免疫疾病期刊（英文） . 2021,第002期
3. Targeting the resolution pathway of inflammation using Ac2–26 peptide-loaded PEGylated lipid nanoparticles for the remission of rheumatoid arthritis [J] . Xianyan Qin, Liming He, Donghao Fan, 亚洲药物制剂科学(英文) . 2021,第004期
4. Impact of Baseline Disease Activity, Disease Duration and Enrolment Year on CDAI and Boolean Remission in Patients with Rheumatoid Arthritis Treated with Anti-TNF-alpha Therapy: An Analysis from a Prospective, Observational Registry [J] . Haraoui Boulos, Starr Michael, Bessette Louis, The Journal of rheumatology . 2016,第6期

机译：基线疾病活动性，疾病持续时间和入组年份对抗TNF-α治疗的类风湿关节炎患者CDAI和布尔缓解的影响：前瞻性观察性注册分析
5. Impact of Baseline Disease Activity, Disease Duration and Enrolment Year on CDAI and Boolean Remission in Patients with Rheumatoid Arthritis Treated with Anti-TNF-alpha Therapy: An Analysis from a Prospective, Observational Registry [J] . Haraoui Boulos, Starr Michael, Bessette Louis, The Journal of rheumatology . 2016,第6期

机译：基线疾病活性，疾病患者对抗TNF-α治疗治疗的患者CDAI和布尔缓解的影响：预期，观察登记处的分析
6. Test-retest reliability of the Disease Activity Score 28 CRP (DAS28-CRP), the Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI) in rheumatoid arthritis when based on patient self-assessment of tender and swollen joints [J] . HeegaardC., DreyerL., EgsmoseC., Clinical rheumatology . 2013,第10期

机译：根据患者对关节压痛和肿胀的自我评估，疾病活动评分28 CRP（DAS28-CRP），简化疾病活动指数（SDAI）和临床疾病活动指数（CDAI）在类风湿关节炎中的重测信度
7. Early disease control by low-dose prednisone comedication may affect the quality of remission In patients with early rheumatoid arthritis [C] . Monica Todoerti, Carlo Alberto Scire, Nicola Boffini, International Conference on the Neuroendocrine Immune Basis of the Rheumatic Diseases . 2010

机译：低剂量泼尼松的早期疾病控制可能会影响早期类风湿性关节炎患者的缓解质量
8. Measuring disease activity and use of complementary and alternative medicine in African-Americans with Rheumatoid Arthritis. [D] . Tamhane, Ashutosh. 2012

机译：测量非裔美国人类风湿关节炎的疾病活动以及补充和替代药物的使用。
9. Comparison of Disease Activity Score in 28 joints with ESR (DAS28) Clinical Disease Activity Index (CDAI) Health Assessment Questionnaire Disability Index (HAQ-DI) Routine Assessment of Patient Index Data with 3 measures (RAPID3) for assessing disease activity in patients with rheumatoid arthritis at initial presentation [O] . B. Siddhartha Kumar, P. Suneetha, Alladi Mohan, 2017

机译：用ESR（DAS28）临床疾病活动指数（CDAI）健康评估问卷残疾指数（HAQ-DI）和患者指数数据的常规评估以及3种测量指标（RAPID3）对28个关节的疾病活动评分进行比较初次出现类风湿关节炎的患者
10. Evaluation of the clinical efficiency of tocilizumab therapy, by using DAS 28, SDAI, CDAI indices and new 2011 EULAR/ACR remission criteria in patients with rheumatoid arthritis [O] . Anastasia Sergeyevna Avdeyeva, E Yu Panasyuk, E N Aleksandrova, 2012

机译：用患者用DAS 28，SDAI，CDAI指数和类风湿性关节炎患者使用DAS 28，SDAI，CDAI指数和新的2011年欧洲/ ACR缓解标准评估临床效率

Differences in disease activity measures in patients with rheumatoid arthritis who achieved DAS, SDAI, or CDAI remission but not Boolean remission

著录项

相似文献

相关主题

期刊订阅